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production of cytokines. Seo et al. show
that Akt phosphorylates cGAS and
dampens its enzymatic activity as well as
anti-viral activity in response to DNA
stimulation and DNA virus infection.
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Upon DNA stimulation, cyclic GMP-AMP synthase
(cGAS) synthesizes the second messenger cyclic
GMP-AMP (cGAMP) that binds to the STING, trig-
gering antiviral interferon-b (IFN-b) production. How-
ever, it has remained undetermined how hosts regu-
late cGAS enzymatic activity after the resolution of
DNA immunogen.Here,we show thatAkt kinaseplays
a negative role in cGAS-mediated anti-viral immune
response. Akt phosphorylated the S291 or S305 resi-
due of the enzymatic domain of mouse or human
cGAS, respectively, and this phosphorylation robustly
suppressed its enzymatic activity. Consequently,
expression of activated Akt led to the reduction of
cGAMPand IFN-bproduction and the increase of her-
pes simplex virus 1 replication, whereas treatment
with Akt inhibitor augmented cGAS-mediated IFN-b
production. Furthermore, expression of the phos-
phorylation-resistant cGAS S291A mutant enhanced
IFN-b production upon DNA stimulation, HSV-1 infec-
tion, and vaccinia virus infection. Our study identifies
anAktkinase-mediatedcheckpoint tofine-tunehosts’
immune responses to DNA stimulation.
INTRODUCTION
Innate immune receptors detect pathogens through pathogen-
associated molecular patterns (PAMPs) and then elicit an im-
mune response (Elinav et al., 2011; Medzhitov and Janeway,
2000). These germ-line-encoded pattern recognition receptors
(PRRs) monitor extracellular, endosomal, and intracellular com-
partments for molecular signatures of microbial infection or
the sometimes overlapping molecular triggers produced by
abnormal, damaged, or dying cells (Latz, 2010). Microbe-derived
nucleic acids are potent cytosolic PAMPs that are recognized by
host PRRs such as the Toll-like receptors (TLRs) and cytosolic
DNA/RNA recognition receptors (Kawai and Akira, 2011). The
appearance of naked DNA in the cytoplasm of mammalian cells
triggers a cellular response initiated by the DNA sensing pathway440 Cell Reports 13, 440–449, October 13, 2015 ª2015 The Authors(Paludan and Bowie, 2013). Cytoplasmic DNA is recognized as
foreign or indicative of cellular distress because nuclear and
mitochondrial membranes typically surround self DNAs. Many
DNA sensors in the cytoplasm have been identified, including
AIM2 (Fernandes-Alnemri et al., 2009; Hornung et al., 2009; Rob-
erts et al., 2009), DAI (Takaoka et al., 2007), DDX41 (Zhang et al.,
2011), DNA-PK (Ferguson et al., 2012), IFI16 (Unterholzner et al.,
2010), and a form of RNA polymerase III that detects AT-rich
DNA (Ablasser et al., 2009; Chiu et al., 2009). Chronic or deregu-
lated activation of nucleic acid sensing has been shown to
contribute to both microbial pathogenesis and autoimmune dis-
eases (Liu et al., 2014; M€unz et al., 2009).
Recently, cyclic GMP-AMP synthase (cGAS) was character-
ized as a primary cytosolic DNA sensor that triggers type I inter-
ferons (IFNs) and other inflammatory cytokines such as tumor
necrosis factor alpha (TNF-a) and interleukin-6 (IL-6) upon DNA
transfection and DNA virus infection (Li et al., 2013; Sun et al.,
2013). Following activation, cGAS converts ATP and GTP into
the dinucleotide cyclic GMP-AMP (cGAMP) (Gao et al., 2013b;
Kranzusch et al., 2013; Wu et al., 2013). cGAMP is a second
messenger that binds to STING, which in turn induces the
recruitment of TANK-binding kinase 1 (TBK1) and interferon reg-
ulatory factor-3 (IRF-3) to form a complex with STING (Ablasser
et al., 2013; Wu et al., 2013). The activation of IRF-3 and/or
nuclear factor kB (NF-kB) signaling pathways induce the expres-
sion of type I IFNs and proinflammatory cytokines. Current struc-
tural and genetic insights into cGAS have focused on its DNA
sensingmechanism and activation. However, it is not well under-
stood how cGAS activity is negatively regulated following activa-
tion. Since both self and non-self DNA can activate cGAS, it is
important to tightly regulate this DNA sensing pathway to pre-
vent harmful activity arising from unrestrained signaling (Bhat
and Fitzgerald, 2014). We have recently reported that the auto-
phagy protein Beclin-1 negatively regulates cGAS function: the
direct interaction between cGAS and Beclin-1 not only sup-
presses cGAMP synthesis to halt IFN production induced by
double-stranded DNA (dsDNA) stimulation or herpes simplex vi-
rus 1 (HSV-1) infection but also enhances the autophagy-medi-
ated degradation of cytosolic pathogen DNAs to avoid persistent
immune stimulation (Liang et al., 2014). Thus, identifying cellular
pathways involved in maintaining a balanced cGAS response is
the primary goal of this study.
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Figure 1. cGAS Is an Akt Substrate
(A) Sequence comparison of the phosphorylated
peptides from human and mouse cGAS. Residues
that support its identity as an Akt substrate motif
are highlighted in red.
(B) Mouse cGAS-FLAG (mcGAS-FLAG) was
immunoprecipitated with anti-FLAG M2 beads
from lysates of 293T cells transiently transfected
with mcGAS-FLAG, HA-myr-Akt1, or vector alone
for 24 hr. Cells were treated for 8 hr with Akt1/2
selective inhibitor VIII (10 mM). The immunopre-
cipitates were probed with Akt phosphosubstrate
and FLAG antibodies. Whole-cell lysates (WCLs)
were probed with antibodies recognizing active
pAkt1 S473, HA, or Actin (loading control).
(C) 293T cells expressing vector alone or HA-myr-
Akt1 were co-transfected with vector (Vec), mouse
cGAS-FLAG (mWT), or mouse cGAS-S291A-
FLAG (S291A) for 24 hr. cGAS-FLAG immunopre-
cipitates were probed with Akt phosphosubstrate
and FLAG antibodies, andWCLswere probedwith
FLAG, HA, or Actin (loading control) antibodies.
(D) Mouse cGAS-FLAG was co-transfected with
vector (Vec), myr-Akt1, myr-Akt2, or myr-Akt3 in
293T cells for 24 hr. cGAS-FLAG immunoprecipi-
tates were probed with the Akt phosphosubstrate
and FLAG antibodies, andWCLswere probedwith
an Akt phosphosubstrate, FLAG, Pan-Akt detecting all Akt isoforms, and Actin (loading control) antibodies.
(E) His-tagged C-terminal fragment of cGAS (amino acids 161–522) WT or with the S291A mutation were used as substrates for in vitro kinase reactions for
immmunoprecipitated active Akt1. His-Gsk protein, the known Akt substrate, is a positive control. Phosphorylation was detected with an Akt phosphosubstrate
antibody. KA, kinase assay; Pos. Con, His-Gsk protein.The protein kinase Akt is one of the most critical and versatile
protein kinases in higher eukaryotes. Numerous Akt substrates
have been identified in relation to metabolism, cell survival, pro-
liferation, and cell migration (Manning and Cantley, 2007). In
addition, Akt may play a role in regulating the IFN pathway.
Mouse fibroblasts treated with type I IFN have activated Akt
that stimulates mammalian target of rapamycin (mTOR), which
is an upstream regulator of IFN-stimulated gene (ISG) translation
(Kaur et al., 2008a). Phosphatidylinositol 3-kinase (PI3K), an Akt
upstream lipid kinase, is activated by type I and type II IFN recep-
tors. Also, p85a and p85b, the regulatory subunits of PI3K, both
cooperate to promote IFN-induced transcription and translation
of ISGs (Kaur et al., 2008b). However, it still remains a question
whether Akt directly controls an upstream mediator of IFN pro-
duction or pattern recognition pathway. Here, we identify a mo-
lecular mechanism in which Akt kinase negatively regulates
cGAS activity. We show that Akt phosphorylates the S291 or
S305 of the carboxyl-terminal enzymatic domain of mouse or hu-
man cGAS, respectively, and that this phosphorylation robustly
suppresses cGAS enzymatic activity. We further reveal that this
phosphorylation is akey regulatory event that inhibits cGASenzy-
matic activity, leading to decreased cytokine production and
antiviral activity toward DNA stimulation and DNA virus infection.
RESULTS
Akt Phosphorylates cGAS
To investigate the molecular mechanism that regulates cGAS
enzymatic activity, we explored the post-translational modifica-Ctions of cGAS bymass spectrometry. Immunoprecipitated cGAS
from 293T cells transiently expressing FLAG-tagged human
cGAS was resolved by SDS-PAGE and analyzed by mass spec-
trometry. We found that human cGAS was phosphorylated at
S305 when overexpressed in 293T cells (Figure S1A). Interest-
ingly, the sequence around S305 includes a known target motif
for Akt kinase (R/KXR/KXX*S/T; X, any amino acid) (Figure 1A)
that is highly conserved across multiple species (Figure S1B).
In mouse cGAS, the homologous residue is S291. Because of
the proximity of S305 or S291 to the catalytic site of human or
mouse cGAS, respectively, we hypothesized that Akt mediates
phosphorylation at this site to control cGAS enzymatic activity.
To validate Akt-mediated phosphorylation, human or mouse
cGAS-FLAG was transiently expressed in 293T cells, followed
by treatment with Akt1/2-specific inhibitor VIII or DMSO as a
control. We resolved the proteins using an SDS-PAGE gel and
immunoblotted with the Akt phosphosubstrate antibody that
specifically recognizes the phosphorylated consensus motif K/
RXK/RXXpS/pT. Both mouse and human cGAS proteins were
readily detected by the Akt phosphosubstrate antibody, which
apparently disappeared upon treatment with Akt inhibitor VIII
(Figures 1B and S2). However, when the phosphorylation resis-
tant S291A mutant of mouse cGAS was expressed, it was not
recognized by the anti-Akt phosphosubstrate antibody (Fig-
ure 1C). Furthermore, Akt’s three isoforms (Akt1, 2, and 3)
were capable of phosphorylating mouse cGAS at equivalent
levels (Figure 1D). Finally, to address whether Akt directly phos-
phorylates cGAS as a substrate, we purified a fragment of
mouse cGAS corresponding to the catalytic region (amino acidsell Reports 13, 440–449, October 13, 2015 ª2015 The Authors 441
Figure 2. Phospho-cGAS Has a Negative Role in Its Enzymatic Activity
(A) A schematic describing site-specific serine 291 phosphorylation with a Sep-accepting tRNA (tRNASep), its cognate phosphoseryl-tRNA synthetase (SepRS),
and elongation factor-Tu (EF-Sep) in an engineered E. coli BL21 strain.
(B) The purification of mouse cGAS WT (mWT) and cGAS pS291 (pS291) protein containing an unnatural pS291 amino acid for in vitro enzymatic assay. Amino
acids 141–507 of mouse cGAS fused toMBPwere purified from an engineered E. coli BL21 strain. Indicated amounts of purified proteins (mg/ml) were loaded and
visualized by Coomassie brilliant blue staining.
(C) Mouse cGAS WT (mWT) and cGAS with the unnatural pS291 amino acid (pS291) were probed with Akt phosphosubstrate and His antibodies.
(D) In vitro enzymatic assays were performed in the presence of P32-a-GTP with amino acids 141–507 of mouse cGAS (mWT) and the same fragment with the
unnatural pS291 amino acid (pS291) purified from engineered E. coli BL21 strain. cGAMP production was analyzed by TLC and autoradiography. The bottom
arrow shows the spotted origin, and the top arrow shows the migrated cGAMP. A representative image was shown, and the right panel shows the plot from
triplicated experiments showing the relative radioactivity of P32-labeled cGAMP normalized to the mock control. *p < 0.05.161–522) fused to maltose binding protein (MBP) in a bacterial
expression vector. A bacterially purified GSK protein was in-
cluded as a positive control. An in vitro kinase assay revealed
that active Akt phosphorylated the cGAS wild-type (WT) frag-
ment, but not the S291A mutant fragment, at the equivalent
level as seen with GSK as a substrate (Figure 1E). Taken
together, these results demonstrate that Akt phosphorylates
the S291 residue or S305 residue of mouse or human cGAS,
respectively.
Serine Phosphorylation Negatively Regulates cGAS
Function
Because cGAS phosphorylation occurs close to its catalytically
important residues (E211, D213, and E302), we tested whether
Akt-mediated phosphorylation could affect cGAS enzyme activ-
ity. To test our hypothesis, we utilized the specific cotranslational
phosphoserine (Sep) incorporation system for the S291 residue
of mouse cGAS (Lee et al., 2013; Park et al., 2011). Sep, the
most abundant phosphoamino acid in the eukaryotic phospho-
proteome, is not encoded in the genetic code, but is synthesized
post-translationally. An Escherichia coli strain was genetically
engineered to harbor a Sep-accepting tRNA (tRNASep), its cog-
nate phosphoseryl-tRNA synthetase (SepRS), and an engi-
neered EF-Tu (EF-Sep) of Methanocaldococcus jannaschii. The442 Cell Reports 13, 440–449, October 13, 2015 ª2015 The AuthorsE. coli strain was then transformed with a bacterial expression
vector containing the His-tagged mouse cGAS fragment (amino
acids 161–522) and the non-natural Sep-incorporated pS291
(directed by UAG) mutant (Figure 2A). We purified both the nat-
ural His-tagged mouse cGAS fragment and the non-natural
amino acid Sep-incorporated pS291 fragment from E. coli (Fig-
ures 2B and 2C) and measured the fragments’ NTase activity
in vitro. While cGAMP production was efficient by mouse
cGAS WT, the phosphorylated (pS291) cGAS showed a nearly
complete loss of cGAMP production (Figure 2D), suggesting
that S291 phosphorylation negatively regulates cGAS enzymatic
activity.
To explore whether this serine phosphorylation affects cGAS-
mediated signaling activity, FLAG-tagged human cGAS, mouse
cGAS, and their phosphorylation-resistant mutants (human
cGAS S305A and mouse cGAS S291A) were stably expressed
in L929 mouse fibrosarcoma cGAS/ cells. Phosphorylation-
resistant cGAS-FLAGmutant-expressing cells showed substan-
tially higher interferon-b (IFN-b) and IL-6 expression upon DNA
stimulation than cGAS-FLAG WT-expressing cells (Figures 3A–
3D), which was specific for DNA stimulation since only poly I:C
stimulation led to equivalent levels of IFN-b and IL-6 induction
in all three L929 cell lines irrespective of cGAS expression and
phosphorylation (Figure 3E; unpublished data). Finally, both
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Figure 3. Serine Phosphorylation Regulates cGAS Activity
(A) L929 cGAS/ cells were stably complemented with empty vector, human cGASWT (hWT), or human cGAS S305A (S305A). Those cell lines were stimulated
with HT-DNA (2 mg/ml) for 9 hr. The expression of IFN-b mRNA was measured by real-time PCR.
(B) L929 cGAS/ cells were stably complemented with empty vector, mouse cGASWT (mWT), or mouse cGAS S291A (S291A). Those cell lines were stimulated
with HT-DNA (2 mg/ml) for 9 hr. The expression of IFN-b mRNA was measured by real-time PCR.
(C) L929 cell lines used in (B) were stimulated with HT-DNA (2 mg/ml) for 18 hr. The production of IFN-b was measured by ELISA.
(D) L929 cell lines used in (B) were stimulated with HT-DNA (2 mg/ml) for 9 hr. The expression of IL-6 mRNA was measured by real-time PCR.
(E) L929 cell lines used in (B) were stimulated with poly I:C (1 mg/ml) for 8 hr. The expression of IFN-b mRNA was measured by real-time PCR.
(F) In vitro enzymatic assayswere performed in the presence of P32-a-GTPwithmouse cGAS (amino acids 141–507)WT and cGASS291A purified from E. coli (left
panel). cGAMP production was analyzed by TLC and autoradiograph (top right panel). The bottom arrow shows the spotted origin, and the top arrow shows the
migrated cGAMP. A representative image was shown, and the right bottom panel shows the plot from triplicated experiments showing the relative radioactivity of
P32-labeled cGAMP normalized to the mock control.
*p < 0.05.bacterially purified mouse cGAS WT and S291A proteins
showed similar cGAMP production activity in vitro (Figure 3F),
suggesting that the lower signaling activity of cGAS WT com-
pared to cGAS S291A mutant appears to be due to its suscepti-
bility to phosphorylation, but not due to its weak enzymatic
activity. Collectively, these results demonstrate that the phos-
phorylation of S291 or S305 dampens cGAS enzymatic activity,
negatively affecting its anti-viral and pro-inflammatory cytokine
production.
Negative Regulation of cGAS Is Mediated by Akt
To test the effect of Akt-mediated phosphorylation on cGAS
function, the myristorylated Akt1 (myr-Akt1, constitutively active
form) or the kinase dead Akt1 (KD) mutant was expressed
in RAW 264.7 cells, followed by DNA stimulation or HSV-1 in-
fection. This showed that upon DNA stimulation or HSV-1 in-
fection, cells expressing myr-Akt1 had significantly reduced
IFN-b expression compared to cells expressing Akt1 KD mutantCor vector alone (Figures 4A and S3A). Additionally, myr-Akt1
expression led to the drastic reduction of cGAS-induced IFN-b
promoter activity (Figure 4B). When myr-Akt1 was expressed
in cGAS/ cells complemented with vector, mouse cGAS
WT, or cGAS S291A, it robustly suppressed herring testes
DNA (HT-DNA) stimulation-induced IFN-b expression in L929
cGAS/ cells complemented with cGAS WT, but not in L929
cGAS/ cells complemented with cGAS S291A mutant (Fig-
ure 4C). Furthermore, when these cells were treated with the
Akt1/Akt2-specific inhibitor VIII, the Akt inhibitor apparently
potentiated DNA stimulation-induced IFN-b mRNA expression
(Figures 4D and S3B). To test whether Akt1 affects the cGAS
downstream cascade, STING agonist, cGAMP was transfected
into the cGAS/ cells complemented with vector, mouse
cGAS WT, or cGAS S291A in the presence or absence of Akt in-
hibitor. IFN-b transcripts and proteins levels were similar after
cGAMP treatment irrespective of Akt inhibitor treatment (Figures
S3C and S3D). It revealed that Akt specifically inhibited cGASell Reports 13, 440–449, October 13, 2015 ª2015 The Authors 443
Figure 4. Akt1 Negatively Regulates cGAS-Mediated Cytokine Production via cGAS Phosphorylation at S291
(A) RAW 264.7 cells were electroporated with vector, myr-Akt1, or kinase dead Akt1 (Akt1 KD), respectively. At 48 hr post transfection, cells were treated with HT-
DNA stimulation (left panel) for 9 hr or infected with HSV-1 (right panel, MOI = 10) for 12 hr. The expression of IFN-b mRNA was measured by real-time PCR.
(B) Akt1 suppression of cGAS-mediated IFN-b promoter activation. HEK293T cells were transfected with human (left panel) or mouse (right panel) cGAS together
with empty vector or HA-myrAkt1. In addition, all samples were co-transfected with STING, IFN-b-Firefly luciferase, and TK-renilla luciferase. Reporter activity
was measured at 16 hr post transfection.
(C) Mouse cGAS variant L929 cell lines were stably expressed with empty vector or myr-Akt1. The expression of IFN-b mRNA was measured by real-time PCR
after HT-DNA stimulation (2 mg/ml) for 9 hr.
(D) L929 cGAS/ cells complemented with empty vector or mouse cGAS WT (mWT) were treated with 5 mM Akt1/2 selective inhibitor VIII or DMSO vehicle and
stimulated with HT-DNA (2 mg/ml) for 9 hr. The expression of IFN-b mRNA was measured by real-time PCR.
(E) Mock or cGAS (amino acids 141–507) WT purified from E. coli were incubated for 30 min with MBP or immunoprecipiated, active Akt1 in the presence of P32-
a-GTP. cGAMP production was analyzed by TLC and autoradiograph. The bottom arrow shows the spotted origin, and the top arrow shows the migrated
cGAMP. A representative image was shown, and the bottom panel shows the plot from triplicated experiments showing the relative radioactivity of P32-labeled
cGAMP normalized to the mock control.
*p < 0.05, **p < 0.005.signaling ability through regulating its enzyme activity. Finally, to
directly address whether Akt1-mediated phosphorylation sup-
presses cGAS enzymatic activity, the bacterially purified cata-
lytic region (amino acids 161–522) of mouse cGAS was mixed
with catalytically active Akt1 in vitro and the mixtures were
then subjected to cGAMP production assay. This revealed that
increasing amounts of Akt1 led to decreasing production of
cGAS-mediated cGAMP in vitro, whereas the addition of MBP
as a control showed only a slight effect on cGAMP production
(Figure 4E). S291A protein resiliently produced cGAMP in the444 Cell Reports 13, 440–449, October 13, 2015 ª2015 The Authorspresence of Akt1, while cGASWT produced undetectable levels
of cGAMP in the same conditions (Figure S4A). After HT-DNA
and/or Akt inhibitor treatment, L929 cell lysates were added
into digitonin-permeabilized THP1-Lucia ISG reporter cells to
perform cGAMP bio-assay. This showed the significant increase
of IFN responsiveness upon Akt inhibitor treatment (Figure S4B).
In summary, the Akt1 kinase directly phosphorylates mouse
cGAS at the S291 residue, leading to the inhibition of cGAS enzy-
matic activity and the suppression of cGAS-mediated IFN-b
production.
Figure 5. The Negative Regulation of cGAS by Akt upon Virus
Infection
(A and B) L929 cGAS/ cells were stably complemented with empty vector,
mouse cGAS WT (mWT), or S291A. The expression of IFN-b mRNA was
measured by real-time PCR after infection with HSV-1WT (MOI = 5; A) or HSV-
1 ICPD34.5 (MOI = 5; B) for 12 hr.
(C) L929 cGAS/ cells complemented with empty vector or mouse cGAS WT
(mWT) were treated with 5 mM Akt1/2 selective inhibitor VIII or DMSO vehicle
and infected with HSV-1WT (MOI = 5) for 12 hr. The expression of IFN-bmRNA
was measured by real-time PCR.
(D) L929 cGAS/ cells were stably complemented with empty vector, mouse
cGASWT (mWT), or S291A. The expression of IFN-bmRNA was measured by
real-time PCR after infection with VSV (MOI = 1) for 8 hr.
*p < 0.05.Akt Antagonizes cGAS-Mediated IFN Response upon
Infection with DNA Viruses
To assess whether Akt antagonizes cGAS-mediated IFN res-
ponse upon infection with DNA viruses, L929 cGAS/ cells
complemented with vector, mouse cGAS WT, or cGAS S291A
were infected with mock or F strain HSV-1 WT or HSV-1
DICP34.5 mutant or the modified vaccina Ankara (MVA), fol-
lowed by the measurement of IFN-b mRNA production. HSV-1
DICP34.5 mutant strain was included as a control since the
GADD34 homology-containing ICP34.5 effectively counteracts
the type I IFN response by binding four cellular proteins, Be-
clin-1, TBK1, protein phosphatase 1a (PP1a), and eukaryotic
translation initiation factor 2a (eIF2a) (Kanai et al., 2012; Li
et al., 2011; Orvedahl et al., 2007). As previously shown (Liang
et al., 2014), expression of cGAS WT induced much higher
amounts of IFN-b mRNA upon HSV-1 DICP34.5 infection than
upon HSV-1 infection. Also, expression of the phosphorylation-
resistant cGAS S291A led to substantially higher IFN-b mRNA
production under the same conditions (Figures 5A and 5B).
MVA infection also induced much higher amounts of IFN-b
mRNA when cells expressing cGAS S291A were compared to
cells expressing cGAS WT (Figure S5A). Next, we determinedCwhether cGAS is phosphorylated by virus infection. We analyzed
cGAS phosphorylation upon HSV-1 infection in a time course.
cGAS was phosphorylated at 8 hr post infection and continued
to be phosphorylated 24 hr post infection (Figure S5B). Interest-
ingly, the kinetics of cGAS phosphorylation were similar to those
of Akt activation asmarked by pAkt S473. Treatment of the Akt1/
Akt2-specific inhibitor VIII further potentiated HSV-1-stimulated
IFN-b mRNA production (Figure 5C), and we also measured
the IFN-b production of L929 cells complemented with cGAS
WT or S291A upon HSV-1 infection after Akt inhibitor treatment
in a time course manner. IFN-b transcripts gradually increased in
L929 cells complemented with phosphorylation resistant mutant
S291A irrespective of Akt inhibitor treatment in the different time
points, while L929 cells complemented with mouse cGAS WT
peaked at 12 hr and then slightly decreased. Akt inhibitor grad-
ually increased IFN-b transcripts in L929 cells complemented
with mouse cGAS WT (Figure S5C). The effect of either cGAS
function or its Akt phosphorylation on IFN-b induction was spe-
cific to HSV-1 infection since its activity was not observed upon
vesicular stomatitis virus (VSV) infection (Figure 5D).
Finally, we sought to determine how Akt1 phosphorylation af-
fects viral replication. L929 cGAS/ cells complemented with
vector, mouse cGAS WT, or cGAS S291A were infected with
HSV-1 or VSV, and the viral titers produced were measured at
different time points up to 48 hr post infection using a standard
plaque formation assay on Vero cells (Figures 6A and 6B). While
mouse cGAS WT expression restricted HSV-1 replication
compared to the vector control, cGAS S291Amutant expression
led to the pronouncedly augmented restriction of HSV-1 replica-
tion (Figure 6A). Since HSV-1D34.5mutant inducedmuch higher
IFN-b production than HSV-1 WT (Figure 5B), we measured the
lytic replication of HSV-1 D34.5 mutant in cGAS-deficient L929
cells complemented with WT cGAS or the S291A cGAS mutant
up to 72 hr post infection (Figure S5D). We observed that HSV-
1 D34.5 mutant production was more apparently reduced in
the S291A cGAS mutant cell line compared to WT. However,
VSV replicated at similar levels irrespective of cGAS WT or
S291A mutant expression (Figure 6B). Furthermore, when myr-
Akt1 was expressed in L929 cGAS/ cells complemented
with vector or mouse cGAS WT, L929 cells co-expressing
cGAS andmyr-Akt1 had a higher viral titer compared to cells ex-
pressing cGAS alone (Figure 6C). On the other hand, myr-Akt1
expression showed no effect on viral production in L929
cGAS/ cells complemented with vector alone (Figure 6C). In
summary, these data collectively indicate that expression of
the Akt phosphorylation-resistant cGAS S291A leads to the
augmented production of anti-viral IFN-b cytokine and the
enhanced inhibition of HSV-1 replication, whereas expression
of the constitutively active Akt1 attenuates the ability of cGAS
to restrict DNA viral replication.
DISCUSSION
Our study identifies a mechanism for Akt kinase-mediated nega-
tive regulation of the cGAS signaling pathway, which potentially
contributes to host health by dampening a prolonged immune
response against pathogens. Importantly, failure to regulate
cGAS activity may lead to excess immune response andell Reports 13, 440–449, October 13, 2015 ª2015 The Authors 445
Figure 6. The Negative Regulation of cGAS Antiviral Activity by Akt
upon Virus Infection
(A and B) The S291A mutation enhances cGAS-mediated antiviral activity to-
ward HSV-1 infection. L929 cGAS/ cells stably complemented with empty
vector, mouse cGAS WT (mWT), or S291A were infected with HSV-1 (MOI =
0.1; A) or VSV (MOI = 0.1; B). Viral supernatants were collected at indicated
times and titered using plaque assays on Vero cells.
(C) Stable myr-Akt1 expression inhibits cGAS activity, leading to high viral
replication. L929 cGAS/ cells stably complemented with empty vector or
mouse cGAS WT (mWT) were infected with HSV-1 (MOI = 0.1). Viral super-
natants were collected at indicated times and titered using plaque assays on
Vero cells.
(D) Proposed model for the functional role of Akt in cGAS-mediated cytokine
production and antiviral activity.
*p < 0.05.inflammatory diseases. We showed that expression of Akt1
repressed cGAS-mediated cytokine production in L929 cells
carrying cGAS WT, but not in L929 cells carrying the phosphor-
ylation-resistant mutant cGAS S291A, whereas treatment with
Akt inhibitor enhanced cytokine production and anti-viral res-
ponse upon infection with DNA viruses as well as DNA stimu-
lation, suggesting that Akt functions as a direct repressor of
cGAS.
Our data unambiguously show that the Akt-mediated phos-
phorylation of cGAS represses IFN-b production, whereas a
phosphorylation-resistant cGAS mutant enhances IFN-b pro-
duction, indicating that Akt1 is a negative regulator of cGAS-
mediated IFN-b production and anti-viral immune response
(Figure 6D). However, this model opposes other published ob-
servations that the activation of the PI3K/Akt pathway is required
for the full induction of ISGs (Kaur et al., 2008a, 2008b). Specif-
ically, it was shown that VSV infection induces Akt phosphoryla-
tion as a part of the host anti-viral response and activation of
PI3K, and Akt is required for the full activation and phosphoryla-
tion of IRF-3 induced by Toll-like receptor 3 (TLR3) and Toll-like
receptor 4 (TLR4) agonists (Schabbauer et al., 2008). Besides446 Cell Reports 13, 440–449, October 13, 2015 ª2015 The AuthorsTLR stimulation, influenza virus infection also activates PI3K
and Akt through a RIG-I-dependent signaling pathway that pro-
motes IRF-3 activation and type 1 IFN expression (Hrincius et al.,
2011). In contrast, we showed Akt kinase was activated upon
HSV-1 infection resulting in cGAS phosphorylation and ulti-
mately leading to decreased IFN-b production (Figures 4A,
S3A, and S5B). We also determined that the MVA robustly
increased IFN-b in phosphorylation-resistant mutant cGAS
S291 cells compared to cGAS WT cells. In addition, the PI3K/
Akt pathway is activated at the early stage of vaccinia virus infec-
tion (Soares et al., 2009), and in some cases, activation of the Akt
pathway by viral infection has a central role in viral replication
and virus-induced apoptosis (Dunn and Connor, 2012). There-
fore, at least someDNA virusesmay have evolutionarily adjusted
Akt-mediated cGAS regulation for their own needs in viral re-
plication as well as for dampening the host innate immune
response. On the other hand, while previous studies suggest
an important role of Akt in anti-viral response, they have mostly
shown the activation of Akt activity upon viral infection but failed
to demonstrate specific roles of activated Akt in downstream
anti-viral pathways. In fact, since Akt is phosphorylated and acti-
vated by TBK1 (Ou et al., 2011), it is possible that activated Akt
suppresses the early step of the PRR pathway as a feedback in-
hibition rather than stimulating a downstream step of the PRR
pathway. While we show that Akt phosphorylates cGAS and
dampens its enzymatic activity, it remains to be determined
what portion of cGAS is phosphorylated by Akt under steady
state or in the context of viral infection. Thus, further study is
needed to dissect the positive or negative role of Akt in anti-viral
immune response upon RNA or DNA viral infection. Neverthe-
less, we show that Akt fine-tunes the IFN-mediated anti-viral
pathway to ultimately ensure that the host DNA sensing innate
immune response is kept in balance after responding to various
stimuli such as DNA virus infections.
The DNA sensor cGAS detects cytosolic DNA species without
a preference for self or non-self DNAs, implying that the DNA
sensor/STING pathway might recognize endogenous DNA spe-
cies that have localized to the cytosol. In agreement with this,
several reports have demonstrated that the immunogenicity
arising from cellular damage may be due to cGAS-induced
sensing of endogenous DNA species and subsequent immune
response (Deng et al., 2014; Ha¨rtlova et al., 2015; Woo et al.,
2014) and that endogenous triggering by TREX1 deficiency
robustly induces cell-autonomous immune response (Ablasser
et al., 2014). Thus, cells should be able to actively regulate
DNA sensing mechanism from being continuously stimulated
by endogenous DNA, such as during cell division when self
DNA is exposed in the cytosol due to nuclear envelope collapse.
The first hypothesis is that a DNA sensor is post-translationally
modified in actively growing cells. In the second hypothesis, a
DNA sensor might require another co-factor to specifically
recognize non-self DNAs or a negative regulator exists to avoid
self DNA recognition. The present work supports the first hy-
pothesis: Akt negatively regulates a primary DNA sensor cGAS
activity by phosphorylating a specific serine residue localized
in its catalytic region, resulting in the suppression of cGAMP syn-
thesis. While it is clear that Akt attenuates the excessive activa-
tion of cGAS in response to DNA exposure, it is intriguing to ask
why growth-factor-induced Akt kinase, among numerous serine-
threonine kinase candidates, modulates cGAS activity. We
speculate that growth factors induce cell division by activating
Akt and the activated Akt subsequently regulates cGAS activity,
preventing the unwanted recognition of self DNA. Thus, it is
important to better understand how DNA sensors such as
cGAS and IFI16 or a safeguard of DNA sensing such as TREX1
are regulated to avoid the excessive response to the triggers of
endogenous DNA.
It has been proposed that there are functional and structural
similarities between oligoadenylate synthase (OAS) proteins
and cGAS (Hornung et al., 2014). Indeed, the OAS proteins
and cGAS are template-independent nucleotidyltransferases
that, once activated by double-stranded nucleic acids in
the cytosol, produce unique classes of 20-50-linked second
messenger molecules, which through distinct mechanisms
have crucial antiviral functions. OAS proteins limit viral propaga-
tion through the activation of the enzyme RNase L, which de-
grades host and viral RNA. 20-50-linked cGAMP activates down-
stream signaling pathways to induce de novo antiviral gene
expression (Hornung et al., 2014). Surprisingly, the predicted
Akt target sequence in OAS1 is also localized in the catalytically
critical region similar to cGAS (Figure S1C). This suggests that
Akt-mediated phosphorylation is a common regulatory mecha-
nism of the OAS family of cytosolic nucleic acid sensors. Further
work is required with respect to the Akt-mediated regulation of
the cGAS-STING and potentially OAS-RNase L pathways, as
their abnormal signaling can initiate a self-perpetuating inflam-
matory response. Regulating Akt activity may be a potential ther-
apeutic strategy for manipulating the PRR-mediated anti-viral
immune response.
EXPERIMENTAL PROCEDURES
Reagents, Constructs, and Cell Culture
The following reagents were purchased: HT-DNA and anti-FLAGM2-agarose
beads (Sigma); Akt1/2 selective inhibitor VIII (EMD Biosciences); interferon-
stimulatory DNA and poly I:C (InvivoGen); and cGAMP (BIOLOG Life Science
Institute). Plasmids were purchased from Addgene (Myr-Akt1, Myr-Akt2, Myr-
Akt3, Myr-Akt1 KD). To clone mouse cGAS, we purchased an expressing
plasmid (GeneCopoeia). Mouse cGAS-FLAG constructs were created by sub-
cloning the PCR products into pER-IRES-puromycin. Mutagenesis by overlap
extension PCR was used to create human cGAS S305A or mouse cGAS
S291A, and the genes were subcloned into pER-IRES-puro. The constructs
were sequenced by Genewiz and were identical to reference cGAS sequences
except for the defined mutations. HEK293T, RAW 264.7, L929WT, L929 cGAS
knockout (Gaoet al., 2013a), andVero cellswere cultured inDMEM (Gibco-BRL)
containing 4mMglutamine and 10% fetal bovine serum (FBS). THP1-Lucia ISG
cells expressed the secreted luciferase (Lucia) reporter geneunder thecontrol of
an IRF-inducible promoter comprising five IFN-stimulated response elements
(ISRE) fused to an ISG54 minimal promoter. Transient transfections were per-
formed with Lipofectamine 2000 (Invitrogen), or calcium phosphate (Clontech
Laboratories), according to the manufacturer’s instructions. Stably expressing
cell lines of vector alone, cGASor Akt in L929 cGAS/ cellswere generated us-
ing a standard selection protocol with 2 mg/ml puromycin or 500 mg/ml G418.
Mass Spectrometry
HEK293T cells were collected 48 hr after transfection with cGAS-FLAG, and
lysed with NP-40 buffer (50 mM HEPES [pH 7.4], 150 mM NaCl, 1 mM
EDTA, 1% [vol/vol] NP-40) supplemented with a complete protease inhibitor
cocktail (Roche) and a Ser/Thr-phosphatase inhibitor cocktail (Sigma). Post
centrifugation, supernatants were mixed with a 50% slurry of FLAGM2 beadsC(Sigma), and the binding reaction mix was incubated for 4 hr at 4C. Precipi-
tates were washed extensively with lysis buffer. Proteins bound to FLAG M2
beads were eluted and separated in a NuPAGE 4 to 12% Bis-Tris gradient
gel (Invitrogen). Following Coomassie brilliant blue staining, protein bands cor-
responding to the expected size of cGAS-FLAG were excised and separately
analyzed by ion-trap mass spectrometry at the Harvard Taplin Biological Mass
Spectrometry Facility.
Dual Luciferase Assay
HEK293T cells were seeded into 12-well plates. 24 hr later, the cells were tran-
siently transfected with 100 ng of IFN-b luciferase reporter plasmid and 20 ng
of TK-renilla luciferase. In addition, 100 ng of plasmid encoding human or
mouse cGAS, 50 ng of plasmid encoding STING, or 400 ngmyr-Akt was trans-
fected as indicated in Figure 2B. 48 hr after transfection, whole-cell lysates
were prepared and subjected to the Dual-Glo luciferase assay according to
manufacturer’s instructions (Promega). Results are presented with renilla lucif-
erase levels normalized by the firefly luciferase levels.
Immunoblot and Immunoprecipitation
Cell lysates were collected in 1% NP-40 buffer and quantified by BCA protein
assay (Thermo Scientific). Proteins were separated by SDS-PAGE and trans-
ferred to the polyvinylidene fluoride (PVDF) membrane (Bio-Rad) by semi-dry
transfer at 25 V for 40min. All membraneswere blocked in 5%milk in Tris-buff-
ered saline (TBST) and probed overnight with indicated antibodies, which are
diluted in the blocking buffer solution at 4C. Primary antibodies included
mouse FLAG (Sigma), rabbit V5 (Bethyl Laboratories), rabbit HA (Covance),
and mouse panAkt (Cell Signaling Technology). HRP-conjugated secondary
antibodies were incubated on membranes in 5% milk in TBST, and bands
were developed with enhanced chemiluminescence (ECL) reagent (Thermo
Scientific) and imaged using a Fuji LAS-4000 imager.
For immunoprecipitation, cells were harvested and then lysed in 1% NP-40
buffer supplemented with a complete protease inhibitor cocktail (Roche). After
pre-clearing with protein A/G agarose beads for 1 hr at 4C, whole-cell lysates
were used for immunoprecipitation with the indicated antibodies. 30 ml of
FLAG M2 beads (Sigma) was added to 1 ml of cell lysates and incubated at
4C for 4 hr. Immunoprecipitates were extensively washed five times with lysis
buffer and eluted with SDS loading buffer by boiling for 5 min.
Protein Purification
Mouse MBP-cGAS fusion protein (amino acids 151–522) was expressed in
BL21 (DE3, RIPL strain; E. coli) and was grown at 37C until reaching
OD600 = 0.6. The temperature was then shifted to 18
C and grown overnight
after adding 1 mM Isopropyl b-D-1-thiogalactopyranoside (IPTG). Cells were
collected by centrifugation and lysed with 1% NP-40 buffer. Clarified lysates
were mixed with nickel-Nitrilotriacetic acid (Ni-NTA) agarose (Invitrogen) and
washed five times with lysis buffer prior to elution of protein using 150 mM
imidazole. The concentrated protein was aliquotted and stored at 80C for
the in vitro cGAS enzyme assay.
The purification of mouse cGAS protein including the unnatural amino acid
was described previously (Shi et al., 2014). Briefly, the Ser291 (AGC) codon
was replaced by the pSer291 (UAG) amber codon by site-directed mutagen-
esis (Stratagene). The plasmid expressing cGAS-291(UAG) and tRNASep was
transformed into E. coli BL21DSerB containing pKD-SepRS-EF-Sep, and
E. coli were grown at 25C for autoinduction, supplemented with solution
including 100 mg ml1 Amp, 50 mg ml1 Kan, 12 mg ml1 Tet, 2 mM Sep,
5,052 solution, and phosphate buffer. After induction, E. coli was harvested,
lysed, subjected to Ni2+-NTA agarose column and anion exchange column pu-
rification. Finally, purified proteins were separated by 10% SDS-PAGE and
stained with Coomassie brilliant blue.
In Vitro Akt Kinase Assay
The in vitro kinase assays using MBP-cGAS and GSK as substrates were per-
formed using a non-radioactive assay (Cell Signaling Technology). Briefly, the
immunoprecipitated phosho-Akt were used in a kinase reaction with 1 mg
MBP-cGAS WT or S291A, or GSK as substrates in the presence of 100 mM
ATP in a kinase assay buffer (25 mM Tris [pH 7.5], 5 mM b-glycerophosphate,
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phosphatase inhibitor cocktail (Sigma). The kinase reaction was performed at
30C for 35 min, and the end products were resolved on 10% SDS-PAGE gel
followed by immunoblotting with the indicated antibodies.
In Vitro cGAS Activity Assay
For in vitro cGAS enzymatic reactions, 1 mMMBP-cGAS or MBP-cGAS variant
was mixed with 250 mM GTP and 10 mCi P32 a phosphate radiolabeled ATP in
buffer (20 mM Tris-Cl [pH 7.5], 150 mM NaCl, 5mMMgCl2, 1 mM DTT). After a
1hr incubation at 37C, the reaction was treated with 5 units of alkaline phos-
phatase (Roche) for 30 min to stop the reaction and 1 ml of reaction solution
was spotted onto thin-layer chromatography (TLC) plates (HPTLC silica gel
60 F254, 20 3 10 cm) with the solvent 1:1.5 [v/v] 1 M (NH4)2SO4 and 1.5 M
KH2PO4. To visualize the reaction, the TLC plates were air dried and imaged
using a Fuji phosphorimager.
RNA Extraction and Real-Time PCR
Total RNA was isolated from cells with TRI Reagent (Sigma). cDNA synthesis
was performed using the iScript cDNA Synthesis kit (Bio-Rad), and qPCR re-
action was monitored with SYBR Green Supermix (Bio-Rad).
ELISA
L929 cells were treated with HT-DNA for 18 hr, and the cell culture supernatant
was collected andmeasured for IFN-b production by sandwich enzyme-linked
immunosorbant assay (ELISA) using amouse IFN-b ELISA kit (PBL Biomedical
Laboratories) according to the manufacturer’s protocols.
Viral Plaque Assays
HSV-1 strain F strain and HSVDICP34.5 (Liang et al., 2014) were grown in Vero
cells propagated in DMEM supplemented with 10% FBS and antibiotics. L929
cells were inoculated with virus in DMEM supplemented with 2% FBS for 1 hr.
After incubation for indicated times (0 hr, 10 hr, 24 hr, 48 hr, 72 hr), culture me-
dia were harvested and the viral titer was determined. Briefly, culture media
from L929 cells were serially diluted in DMEM supplemented with 10% FBS
and used to infect 80% confluent monolayers of Vero cells growing in 6-well
plates. After infection, the monolayers were rinsed and overlaid with 7%meth-
ylcelluose. Plaques were counted after 3 to 5 days.
cGAMP Bio-assay
L929 cells treated with HT-DNA or Akt inhibitor for 9 hr were trypsinized and
washed with PBS. Freezing and thawing after storage at 80C lysed the pel-
leted cells. Cell extracts were incubated with Benzonase and heat-treated as
previously reported (Wu et al., 2013). IRF-responsive THP-1 ISG54-Lucia cells
(InvivoGen) were cultured in RPMI 1640 supplemented with 10% FBS and an-
tibiotics. Samples of cell lysates were mixed with a digitonin permeabilization
solution (50 mM HEPES [pH 7.0], 100 mM KCl, 3 mM MgCl2, 0.1 mM DTT,
85 mM sucrose, 0.2% BSA, 1 mM ATP, 10 mg/ml digitonin). The mixtures
were incubated for 30 min at 37C in microcentrifuge tubes. The precipitated
cells were dissolved in RPMI complete medium and incubated for 18 hr before
luciferase measurement. Whole-cell lysates were prepared and subjected to
the renilla luciferase assay reagent according to manufacturer’s instructions
(Promega). cGAMP was used as a standard.
Statistical Analysis
All data were analyzed using a two-tailed Student’s t test with aminimumof n =
3. p values less than 0.05 were considered significant. *p < 0.05, **p < 0.005.
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